1. Home
  2. EDSA vs INBS Comparison

EDSA vs INBS Comparison

Compare EDSA & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • INBS
  • Stock Information
  • Founded
  • EDSA 2015
  • INBS 2016
  • Country
  • EDSA Canada
  • INBS United States
  • Employees
  • EDSA N/A
  • INBS N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • INBS Medical Specialities
  • Sector
  • EDSA Health Care
  • INBS Health Care
  • Exchange
  • EDSA Nasdaq
  • INBS Nasdaq
  • Market Cap
  • EDSA 6.2M
  • INBS 6.4M
  • IPO Year
  • EDSA N/A
  • INBS N/A
  • Fundamental
  • Price
  • EDSA $1.70
  • INBS $1.39
  • Analyst Decision
  • EDSA Strong Buy
  • INBS
  • Analyst Count
  • EDSA 1
  • INBS 0
  • Target Price
  • EDSA $21.00
  • INBS N/A
  • AVG Volume (30 Days)
  • EDSA 17.7K
  • INBS 89.3K
  • Earning Date
  • EDSA 02-07-2025
  • INBS 02-07-2025
  • Dividend Yield
  • EDSA N/A
  • INBS N/A
  • EPS Growth
  • EDSA N/A
  • INBS N/A
  • EPS
  • EDSA N/A
  • INBS N/A
  • Revenue
  • EDSA N/A
  • INBS $3,187,974.00
  • Revenue This Year
  • EDSA N/A
  • INBS $280.88
  • Revenue Next Year
  • EDSA N/A
  • INBS $126.26
  • P/E Ratio
  • EDSA N/A
  • INBS N/A
  • Revenue Growth
  • EDSA N/A
  • INBS 55.29
  • 52 Week Low
  • EDSA $1.55
  • INBS $1.00
  • 52 Week High
  • EDSA $5.99
  • INBS $11.70
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 40.80
  • INBS 47.99
  • Support Level
  • EDSA $1.56
  • INBS $1.27
  • Resistance Level
  • EDSA $1.97
  • INBS $1.45
  • Average True Range (ATR)
  • EDSA 0.15
  • INBS 0.08
  • MACD
  • EDSA 0.02
  • INBS 0.00
  • Stochastic Oscillator
  • EDSA 31.84
  • INBS 44.44

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).

Share on Social Networks: